SXULTRASONIC | APPLICATIONS

Solutions for Life Science Research

The contents below are the overviews of peer-reviewed journal articles citing SXULTRASONIC's products and solutions

Low-Intensity Pulsed Ultrasound Counteracts Advanced Glycation End Products-Induced Corpus Cavernosal Endothelial Cell Dysfunction via Activating Mitophagy

Release date:2023.03.26 classification:LIPUSTIM® Sonodynamic Therapy Solutions
Low-intensity pulsed ultrasound ameliorates erectile dysfunction induced by bilateral cavernous nerve injury through enhancing Schwann cell-mediated cavernous nerve regeneration

Release date:2023.03.26 classification:LIPUSTIM® Sonodynamic Therapy Solutions
Hollow Co-CeO2@PEG nanospheres Ultrasound enhanced cascade-nanozyme for synergetic anticancer

Release date:2023.02.02 classification:LIPUSTIM® Sonodynamic Therapy Solutions
Hollow CoP@N-Carbon Nanospheres: Heterostructure and Glucose-Enhanced Charge Separation for Sonodynamic/Starvation Therapy

Release date:2023.02.02 classification:LIPUSTIM® Sonodynamic Therapy Solutions
Urea-Bond Scission Induced by Therapeutic Ultrasound for Biofunctional Molecule Release

Release date:2022.09.07 classification:LIPUSTIM® Sonodynamic Therapy Solutions

1 2 3 4 5 Next page Last page

Shenzhen